About PPHI

 Mike was Founder and former legacy President of Pennside Partners Ltd., a leading Pharma consultancy offering competitive insights into clinical and commercial aspects of Rx Pharma lifecycles for the past thirty years. His tenacious focus on high performing Launch, LCM and Market Access functions within global Pharma has underpinned several dozen high performance Rx launches in the last two decades. The PPL business was acquired by Two Labs/ Envision in Fall of 2018, where Mr. Rhoads remained active until gearing up Pennside Partners Holdings more recently. PPHI serves as the vehicle for all finance, equity investment and consulting activities worldwide.

 Mr. Rhoads has deep clinical, marketing and financial credentials across most primary care and specialty sectors of global pharma, complementing three decades of commercial benchmarking and market access innovation. This expertise has led to direct tactical engagements for a host of mega-blockbuster launches across primary care and specialty/biopharma categories since 1990. He has led over 500 plus engagements applying cross-functional competitive strategy, intelligence and launch support across the US, EU, Japan & China. 

Since early this decade, Mr. Rhoads has honed an acute focus on best practices to support integrated Market & Patient Access in North America and major European markets. These client activities draw on strong acumen in Rx Life Cycle Management and associated clinical and commercial tactics for optimal launch adoption and brand life extension. His legacy client roster includes most major Pharma and leading Biotech concerns. (Client list available upon request)